HC

Hymavathi Chiluka

Active Director Director DIN 09037398
DIN 09037398 First appointment Jan 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2021
Shareholding value •••• Premium profile

About Hymavathi Chiluka

Data last updated:

Hymavathi Chiluka is a Director at Rochishmati Pharma Private Limited (since 2021). The company operates in Trading. Rochishmati Pharma Private Limited reported revenue of ₹23.5 Lakh (FY 2024).

DIN 09037398
Primary Designation Director
Industry Trading
First Appointment 21 Jan 2021
Oldest Company Age 5 yrs
Largest company Rochishmati Pharma Private Limited · ₹23.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rochishmati Pharma Private Limited U51909TG2021PTC147913
Director21 Jan 20212021₹23.5 Lakh (FY 2024)Active

Board colleagues of Hymavathi Chiluka

Directorship timeline

Open interactive timeline →
Rochishmati Pharma Private Limited
Premium access

Shareholding and investment profile for Hymavathi Chiluka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hymavathi Chiluka

Hymavathi Chiluka currently holds 1 directorship: Rochishmati Pharma Private Limited (Director, since 21 Jan 2021, revenue ₹23.5 Lakh (FY 2024)).

Hymavathi Chiluka was first appointed on 21 Jan 2021 as Director at Rochishmati Pharma Private Limited.

The current boards of Hymavathi Chiluka's companies include Madhire Shiva Shankar (Rochishmati Pharma Private Limited), Satish Todupunoori (Rochishmati Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available